Virginie Westeel, MD, PhD, on Managing Immune-Related Adverse Events Associated With Checkpoint Inhibitor Therapy

Posted: Tuesday, November 14, 2017

How do you work with non-oncology specialists who must collaborate with you to manage patients’ complications from checkpoint inhibitors?